肛裂治療市場：依治療類型、給藥途徑、通路及地區分類

Anal Fissure Treatment Market, By Treatment Type, By Route of Administration, By Distribution Channel, By Geography

出版日期: 2025年03月27日 | 出版商:

Coherent Market Insights | 英文 160 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

肛裂治療市場在 2025 年的價值估計為 11.521 億美元，預計到 2032 年將達到 16.538 億美元，2025 年至 2032 年的年複合成長率為 5.3%。

報告範圍		報告詳細資訊
基準年	2024	2025年的市場規模	11.521億美元
效能數據	從2020年到2024年	預測期	2025年至2032年
預測期：2025-2032年年複合成長率：	5.30%	2032年價值預測	16.538億美元

肛裂是一種常見的疾病，影響著世界各地的許多人。肛壁上會出現小裂痕或切口，引起不適、疼痛，有時還會導致排便時出血。肛裂可能會自行癒合，但通常需要治療以緩解症狀並促進癒合。

大多數肛裂會在幾週內自然癒合，但如果沒有癒合，可能會出現併發症。這種情況稱為慢性肛裂。肛裂不但不會癒合，反而會持續失控地螺旋式發展，留下疤痕。

肛裂的症狀包括排便時疼痛、排便後疼痛持續數小時、排便後糞便中或廁所用衛生紙上有鮮紅色血液、肛門周圍皮膚出現明顯裂紋、肛裂附近皮膚出現小腫塊或皮贅。

由於全球範圍內肛裂盛行率的不斷上升，全球肛裂治療市場正在經歷顯著成長。久坐的生活方式、不良的飲食習慣、人口老化等因素導致肛裂發生率上升。人們對各種治療方案的認知不斷提高，以及對微創手術的需求不斷成長，進一步推動了市場的成長。

市場動態：

預計預測期內，全球肛裂盛行率的上升以及市場參與企業產品上市的增加將推動市場成長。例如，根據《臨床醫學》雜誌2022年9月15日發布的數據，新墨西哥州一般人口肛裂的年發生率為0.11%。

本研究的主要特點

本研究報告對全球肛裂治療市場進行了全面的分析，並提供了預測期為2025年至2032年的市場規模和年複合成長率（CAGR%），以2024年為基準年。
該報告揭示了各個領域的潛在商機，並為該市場提供了一個引人注目的投資提案矩陣。
它提供了有關市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域前景和主要企業採用的競爭策略的重要見解。
它介紹了全球肛裂治療市場的主要企業，重點介紹了他們的公司背景、產品系列、財務表現和策略。
本報告的見解將使企業負責人和經營團隊能夠就產品發布、市場擴張和行銷策略做出明智的決策。
全球肛裂治療市場報告針對行業中的各個相關人員，例如投資者、供應商、產品製造商、經銷商、新進業者和金融分析師。
相關人員可以透過分析全球肛裂治療市場的各種策略矩陣做出明智的決策。

Report Coverage	Report Details
Base Year:	2024	Market Size in 2025:	USD 1,152.1 Mn
Historical Data for:	2020 To 2024	Forecast Period:	2025 To 2032
Forecast Period 2025 to 2032 CAGR:	5.30%	2032 Value Projection:	USD 1,653.8 Mn

Anal fissure is a common medical condition that affects a significant number of individuals worldwide. It refers to a small tear or cut in the lining of the anus, resulting in discomfort, pain, and sometimes bleeding during bowel movements. While anal fissures can heal on their own, it often require treatment to alleviate symptoms and promote healing.

Many anal fissures heal by themselves in a few weeks, but complications can develop when they don't. These are called chronic anal fissures. Instead of healing, they continue to reinforce themselves in a vicious cycle, leaving a persistent wound.

Symptoms of anal fissure includes; Pain during bowel movements, Pain after bowel movements that can last up to several hours, Bright red blood on the stool or toilet paper after a bowel movement, a visible crack in the skin around the anus, a small lump or skin tag on the skin near the anal fissure

Global anal fissure treatment market is witnessing significant growth due to increasing prevalence of anal fissures globally. Factors such as sedentary lifestyles, poor dietary habits, and rising aging population contribute to growing incidence of anal fissures. Rising awareness about the availability of various treatment options and increasing demand for minimally invasive procedures are further driving the market growth.

Market Dynamics:

Increasing prevalence of anal fissure globally and increasing product launches by the market players are expected to aid drive the market growth over the forecast period. For instance, on September 15, 2022, according to the data published by the Clinical Medicine, annual incidence of anal fissures in the general population is 0.11% in New Mexico.

Key Features of the Study:

This study provides a comprehensive analysis of the global anal fissure treatment market, including market size (US$ Mn) and compound annual growth rate (CAGR%) for the forecast period of 2025-2032, with 2024 as the base year
The report elucidates potential revenue opportunities across different segments and offers attractive investment proposition matrices for this market
It provides key insights into market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
The profiles of key players in the global anal fissure treatment market are included, highlighting their company background, product portfolio, financial performance, and strategies
Key companies covered in this study include Abvie, Novartis AG, Teva Pharmaceuticals, Troikaa, RDD Pharma, Ltd, Kyowa Kirin Co., Ltd, Cipla Inc., Ipsen Pharma, Sanofi, Boehringer Ingelheim International GmbH, Bliss GVS, SRS Life Sciences, Healthy Life Pharma Private Limited, and Geri-Care Pharmaceuticals Corp
The insights from this report enable marketers and management authorities of companies to make informed decisions regarding product launches, market expansion, and marketing tactics
Global anal fissure treatment market report caters to various stakeholders in the industry, including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders can make informed decisions through different strategy matrices used in analyzing the global anal fissure treatment market

Anal Fissure Treatment Market Detailed Segmentation:

By Treatment Type
- Laxatives
- Topical Nitrates
- Calcium Channel Blockers
- Stool Softeners
- Surgery
- Others
By Route of Administration
- Oral
- Topical
- Others
By Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
By Region:
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East
- Africa
Company Profiles
- Abvie
- Novartis AG
- Teva Pharmaceuticals
- Troikaa
- RDD Pharma, Ltd
- Kyowa Kirin Co., Ltd
- Cipla Inc.
- Ipsen Pharma
- Sanofi
- Boehringer Ingelheim International GmbH.
- Bliss GVS
- SRS Life Sciences
- Healthy Life Pharma Private Limited
- Geri-Care Pharmaceuticals Corp.

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Anal Fissure Treatment Market, By Treatment Type
- Anal Fissure Treatment Market, By Route of Administration
- Anal Fissure Treatment Market, By Distribution Channel
- Anal Fissure Treatment Market, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
Increasing Prevalence of Anal Fissures
Rising Awareness and Removing Social Stigma
- Restraints
Social Taboo Inhibiting Treatment Seeking
Product Recall
- Opportunities
Huge Scope in Emerging Economies
Growing Demand for Minimally Invasive Procedures
Impact Analysis
Key Highlights
Regulatory Scenario
Product Launches/Approvals
PEST Analysis
PORTER's Analysis
Merger and Acquisition Scenario

4. Global Anal Fissure Treatment Market - Impact of Coronavirus (COVID-19) Pandemic

COVID-19 Epidemiology
Supply Side and Demand Side Analysis
Economic Impact

5. Global Anal Fissure Treatment Market, By Treatment Type, 2020-2032, (US$ Mn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Laxatives
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Mn)
Topical Nitrates
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Mn)
Calcium Channel Blockers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Mn)
Stool Softeners
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
Surgery
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Mn)

6. Global Anal Fissure Treatment Market, By Route of Administration, 2020-2032, (US$ Mn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021- 2032
- Segment Trends
Oral
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Mn)
Topical
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Mn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Mn)

7. Global Anal Fissure Treatment Market, By Distribution Channel, 2020-2032, (US$ Mn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021- 2032
- Segment Trends
Hospital Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Mn)
Retail Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Mn)
Online Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Mn)

8. Global Anal Fissure Treatment Market, By Region, 2020-2032, (US$ Mn)

Introduction
- Market Share Analysis, By Region, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, For Region, 2021-2032
- Country Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2020-2032, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020-2032, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2032, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Mn)
  - U.S.
  - Canada
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2020-2032, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020-2032, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2032, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Mn)
  - U.K.
  - Germany
  - France
  - Italy
  - Spain
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2020-2032, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020-2032, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2032, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Mn)
  - China
  - Japan
  - India
  - Australia
  - South Korea
  - ASEAN
  - Rest of Asia Pacific
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2020-2032, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020-2032, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2032, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Mn)
  - Brazil
  - Mexico
  - Argentina
  - Rest of Latin America
Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2020-2032, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020-2032, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2032, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Mn)
  - GCC
  - Israel
  - Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2020-2032, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020-2032, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2032, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2020-2032, (US$ Mn)
  - South Africa
  - North Africa
  - Central Africa

9. Competitive Landscape

Abbvie
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Novartis AG
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Teva Pharmaceuticals
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Troikaa
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
RDD Pharma, Ltd
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Kyowa Kirin Co., Ltd
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Cipla Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Ipsen Pharma
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Sanofi
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Boehringer Ingelheim International GmbH
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Bliss GVS
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
SRS Life Sciences
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Healthy Life Pharma Private Limited
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Geri-Care Pharmaceuticals Corp
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Analyst Views